These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 2694764)

  • 1. Clinical evaluation of acetylsalicylic acid to improve glycemia in type II diabetic patients.
    Mata-Segreda JF; Fernández-Azofeifa E; Madrigal X; Morales AC
    Acta Physiol Pharmacol Latinoam; 1989; 39(1):9-13. PubMed ID: 2694764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
    Vilsbøll T; Krarup T; Madsbad S; Holst JJ
    Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of acetylsalicylic acid on blood glucose and insulin in non-insulin dependent diabetes.
    Tornvall G; Allgén LG
    Acta Endocrinol Suppl (Copenh); 1980; 239():6-8. PubMed ID: 7001843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
    Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
    Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [C-peptide determination in diabetics for the evaluation of insulin requirements].
    Keller U; Pasquel M; Berger W
    Schweiz Med Wochenschr; 1987 Feb; 117(6):187-92. PubMed ID: 3551060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in adult onset (type II) diabetes mellitus.
    Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Petrescu E; Sackett-Lundeen L; Stelea S; Stelea P
    Endocrinologie; 1984; 22(1):3-16. PubMed ID: 6369501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics of insulin Lispro in 2 patients with type II diabetes mellitus.
    Jehle PM; Fussgänger RD; Seibold A; Lüttke B; Böhm BO
    Int J Clin Pharmacol Ther; 1996 Nov; 34(11):498-503. PubMed ID: 8937933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of acarbose on postprandial increase in blood glucose. Additive acute effect of once daily administration in insulin treated diabetes].
    Ledermann H; Höxter G
    Fortschr Med; 1994 Nov; 112(32):467-70. PubMed ID: 7821886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Incidence of severe hypoglycemia in relation to metabolic control and patient knowledge].
    Ratzmann KP; Schimke E
    Med Klin (Munich); 1995 Oct; 90(10):557-61. PubMed ID: 7500918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients.
    Rizkalla SW; Elgrably F; Tchobroutsky G; Slama G
    Diabete Metab; 1986 Aug; 12(4):219-24. PubMed ID: 3533670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.
    Shichiri M; Kishikawa H; Ohkubo Y; Wake N
    Diabetes Care; 2000 Apr; 23 Suppl 2():B21-9. PubMed ID: 10860187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
    Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH
    Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of insulin and glibenclamide in the treatment of elderly non-insulin dependent (type 2) diabetic patients.
    Kyllästinen M; Groop L
    Ann Clin Res; 1985; 17(3):100-4. PubMed ID: 3931537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasma glucagon and insulin profile in obese non-diabetic and non-insulin-dependent diabetic patients on a daily 800 calorie diet].
    Balázsi I; Varsányi-Nagy M; Nagy K
    Orv Hetil; 1986 Aug; 127(33):2009-13. PubMed ID: 3537903
    [No Abstract]   [Full Text] [Related]  

  • 15. [Role of physical activity in the therapy and prevention of Type II diabetes mellitus].
    Lehmann R; Spinas GA
    Ther Umsch; 1996 Dec; 53(12):925-33. PubMed ID: 9036570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients.
    Paquot N; Scheen AJ; Dirlewanger M; Lefèbvre PJ; Tappy L
    Obes Res; 2002 Mar; 10(3):129-34. PubMed ID: 11886934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diacylglycerol-induced improvement of whole-body insulin sensitivity in type 2 diabetes mellitus: a long-term randomized, double-blind controlled study.
    Li D; Xu T; Takase H; Tokimitsu I; Zhang P; Wang Q; Yu X; Zhang A
    Clin Nutr; 2008 Apr; 27(2):203-11. PubMed ID: 18314230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biphasic insulin aspart 30 three times daily is more effective than a twice-daily regimen, without increasing hypoglycemia, in Chinese subjects with type 2 diabetes inadequately controlled on oral antidiabetes drugs.
    Yang W; Ji Q; Zhu D; Yang J; Chen L; Liu Z; Yu D; Yan L
    Diabetes Care; 2008 May; 31(5):852-6. PubMed ID: 18268073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Basal blood level of thyroxine in diabetes mellitus patients].
    Vakov L; Zakharieva B
    Vutr Boles; 1987; 26(1):60-5. PubMed ID: 3590731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the short-term, intense exercise on postprandial glycemia in type 2 diabetic patients treated with gliclazide.
    Szewieczek J; Dulawa J; Strzałkowska D; Hornik B; Kawecki G
    J Diabetes Complications; 2007; 21(2):101-7. PubMed ID: 17331858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.